The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
about
Parkinson's disease as a result of agingCritical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease.Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegenerationGlial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.Methionine in Proteins: It's Not Just for Protein Initiation Anymore.Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?An energy systems approach to Parkinson's disease.Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.
P2860
Q28084395-BE1D7849-3D78-4326-8E9B-191499183789Q33894382-462F9F47-B521-4BA7-8176-A0040D3D98A9Q35997646-FC629E7C-ADFD-4BD2-BB2C-B475FD769CA7Q36499640-7E71AE77-6EC7-4007-957F-48ADD1603D0DQ36976137-78E38DC0-2AF0-47CA-98E2-041FC0BB4CB7Q37270004-366BAD85-497F-4783-8062-F6D9D1AB6383Q37333346-60FF3F8F-4009-49B4-A277-0C36E7CCED1BQ37363512-490055B0-94E8-4FCA-B8E0-5B2F3560AFF7Q38570991-9D7F12F1-FA86-48DF-8852-D80CD41CF7C9Q41758570-FDCBF13D-1F14-4014-94F4-D7514B454F8FQ48256084-AC05E90E-C3EB-4D64-9228-4785CBB96AE7Q48946263-45702D73-CBF9-4C72-BC2B-3762B02CE952Q51639388-88FE65D3-881A-4DC8-9DE4-56C82C3EB1A3Q53392035-4DEF8770-1601-462F-BA93-FB5D281A8020
P2860
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
@ast
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
@en
type
label
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
@ast
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
@en
prefLabel
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
@ast
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
@en
P2093
P2860
P50
P1476
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
@en
P2093
Charles Duyckaerts
Davis Parker
Donald Price
Donato A Di Monte
Eldad Melamed
Peter Jenner
Walter Rocca
William J Langston
Yoav Ben-Shlomo
P2860
P304
P356
10.1097/NEN.0B013E318053716A
P50
P577
2007-05-01T00:00:00Z